Invention Grant
- Patent Title: Substituted heteroaryl fused derivatives as P13K inhibitors
- Patent Title (中): 取代的杂芳基稠合衍生物作为P13K抑制剂
-
Application No.: US14290185Application Date: 2014-05-29
-
Publication No.: US09403847B2Publication Date: 2016-08-02
- Inventor: Andrew P. Combs , Yun-Long Li , Eddy W. Yue , Richard B. Sparks
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D519/00
- IPC: C07D519/00 ; A61K31/52
Abstract:
The present invention provides fused derivatives of Formula I: that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Public/Granted literature
- US20140275127A1 SUBSTITUTED HETEROARYL FUSED DERIVATIVES AS PI3K INHIBITORS Public/Granted day:2014-09-18
Information query
